March-April, 2022, UBS, Kiplinger, and Barron's analysts and reporters combined to list five sets of stocks sorted as: “Inflation Busters.” Those five articles revealed 48 equities, with 43 paying
It's among the prohibitively expensive biologic pharmaceuticals being replaced by cheaper “biosimilar” copycats. Relief is on the way for patients who need Humira, a product made by AbbVie.
Investor sentiment has improved this year on expectations of less-aggressive interest rate hikes by the Federal Reserve to tame inflation. However, the ongoing macro uncertainty continues to create co
Does this deal make CVS a better investment today?
I perform a deep dive analysis of my dividend growth income portfolio for which I currently provide monthly income updates. In the past 12 months, this portfolio has beaten the S&P 500 by a noticeable

Final Trades: CVS, Alphabet, Activision & more

02:17pm, Friday, 10'th Feb 2023
The "Halftime Report" traders give their top picks to watch for the second half.
CVS Health (NYSE: CVS) is buying Oak Street Health (NYSE: OSH) for $10.6 billion. These are the details.

Stop Playing Short Term With CVS

09:35am, Thursday, 09'th Feb 2023
CVS is becoming engrained in U.S. medical care. Recent acquisitions are not added in great forward guidance.
On Wednesday, CVS Health Corp. ( CVS , Financial) announced a deal that has been a long time in the making. As the next step in its growth plan, the retail pharmacy giant has agreed to acquire primary
CVS Health CEO Karen Lynch joins 'Closing Bell' to discuss CVS's latest primary care deal with Oak Street Health, mapping out the end of Covid, and providing women with health care products, including
CVS Health's $10.6 billion acquisition of Oak Street Health will provide new revenue at a time when growth in its legacy pharmacy and retail businesses is expected to slow down.
The price action in CVS Health (NYSE: CVS) has been coiling up over the last 15 months and it looks ready to spring higher. The latest earnings report confirms the trend and trajectory of growth and h

CVS buying Oak Street Health for $10.6B

12:55pm, Wednesday, 08'th Feb 2023
CVS Health announced plans for them to acquire primary health company Oak Street Health for $39 a share, at a total purchase price of approximately $10.6 billion.
Yahoo Finance Live anchors discuss fourth-quarter earnings for CVS.
CVS Health Corp (NYSE:CVS) which has reportedly been in the market for a medical services acquisition since last year, agreed to snap up Oak Street Health Inc, a primary care company that offer routin
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE